Cargando…
Dexmedetomidine Alleviates LPS-Induced Neuronal Dysfunction by Modulating the AKT/GSK-3β/CRMP-2 Pathway in Hippocampal Neurons
OBJECTIVE: Dexmedetomidine, an α2-adrenergic receptor agonist, mitigates cognitive dysfunction in elderly patients after surgery with general anesthesia. However, the underlying mechanism by which dexmedetomidine reduces cognitive dysfunction remains to be fully elucidated. The aim of this study was...
Autores principales: | Zeng, Wei, Zhang, Chunyuan, Long, Qingshan, Li, Yalan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955869/ https://www.ncbi.nlm.nih.gov/pubmed/33727816 http://dx.doi.org/10.2147/NDT.S297365 |
Ejemplares similares
-
PTEN and AKT/GSK-3β/CRMP-2 signaling pathway are involved in neuronal apoptosis and axonal injury in early brain injury after SAH in rats
por: Chen, Hong, et al.
Publicado: (2020) -
Targeting of CRMP-2 to the Primary Cilium Is Modulated by GSK-3β
por: Ou, Young, et al.
Publicado: (2012) -
CRMP2 and CRMP4 Are Differentially Required for Axon Guidance and Growth in Zebrafish Retinal Neurons
por: Liu, Zhi-Zhi, et al.
Publicado: (2018) -
GSK3β Interacts With CRMP2 and Notch1 and Controls T-Cell Motility
por: Fazil, Mobashar Hussain Urf Turabe, et al.
Publicado: (2021) -
CRMP5 Regulates Generation and Survival of Newborn Neurons in Olfactory and Hippocampal Neurogenic Areas of the Adult Mouse Brain
por: Veyrac, Alexandra, et al.
Publicado: (2011)